Patients Return on Engagement (ROE): A new framework to better captur... Return on Engagement (ROE) is a call to action to better capture the multifaceted value of patient engagement.
Digital Why pharma’s digital health tools miss the mark Explore the cultural, operational, and value-definition shifts required for digital health to deliver durable impact.
Digital Improving ROI on AI investments and data quality, with Dr Ja... Dr Jay Anders, chief medical officer for Medicomp Systems, discusses why he believes that the only way to solve AI ROI issues is to solve data quality
Market Access Capital efficient trials in a time of economic uncertainty In the current climate of capital constraints, tariffs, and policy uncertainty, as well as changing regulatory dynamics, pharma and biotech companies should address not just whether a trial
R&D From promise to reality: Unlocking the true business potenti... The genomic medicine space has seen incredible success, but investors are overlooking it.
Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
